Thermo Fisher Scientific | TMO - Ebit

Aktienkurs
479.15
Täglich Wechseln
12.89 2.76%
Monatlich
-2.52%
Jährlich
14.11%
Q2 Prognose
459.66




Ebit Veränderung Datum
Abbott USD 1.85B 684M 2026-03
Agilent USD 353M 90M 2025-12
Becton, Dickinson and Co. USD 663M 163M 2025-12
Bio Techne USD 54.46M 6.8M 2025-12
Bio-Rad Laboratories USD 941.3M 1.36B 2025-12
Boston Scientific USD 1.05B 190M 2026-03
Bruker USD 76.3M 7.6M 2025-12
Charles River Laboratories USD 75.82M 57.98M 2025-12
Danaher USD 1.34B 158M 2026-03
Dentsply International USD 538M 26M 2025-12
Edwards Lifesciences USD 514.7M 144.4M 2026-03
General Electric Aerospace USD 2.09B 416M 2026-03
Henry Schein USD 186M 12M 2025-12
Illumina USD 256M 6M 2025-12
Intuitive Surgical USD 859.7M 5.6M 2026-03
IQVIA Holdings USD 2.68B 2.1B 2025-12
Laboratory Of America USD 382M 11M 2025-12
Medtronic USD 1.74B 40M 2025-12
Mettler Toledo International USD 351.93M 57.73M 2025-12
Myriad Genetics USD -3M 20.3M 2025-12
Olympus JPY 28B 5.56B 2025-12
OraSure Technologies USD -13.59M 2.13M 2025-12
Quest Diagnostics USD 399M 13M 2026-03
Repligen USD 19.97M 3.16M 2025-12
Revvity USD 145.83M 47.49M 2025-12
Stryker USD 1.97B 609M 2025-12
Thermo Fisher Scientific USD 1.91B 389M 2026-03
Veracyte USD 24.63M 1.52M 2025-12
Waters USD 270.52M 78.4M 2025-12
Zimmer Biomet Holdings USD 395.1M 92.2M 2026-03